(Q30419820)

16 August 2017

Birth outcomes in women who have taken leflunomide during pregnancy (English)

1 reference

16 August 2017

1 reference

Christina D Chambers

1

1 reference

16 August 2017

Diana L Johnson

2

1 reference

16 August 2017

Luther K Robinson

3

1 reference

16 August 2017

Stephen R Braddock

4

1 reference

16 August 2017

Ronghui Xu

5

1 reference

16 August 2017

Janina Lopez-Jimenez

6

1 reference

16 August 2017

Nicole Mirrasoul

7

1 reference

16 August 2017

Elizabeth Salas

8

1 reference

16 August 2017

Yunjun J Luo

9

1 reference

16 August 2017

Shelia Jin

10

1 reference

16 August 2017

Kenneth Lyons Jones

11

1 reference

16 August 2017

Organization of Teratology Information Specialists Collaborative Research Group

12

1 reference

16 August 2017

1 May 2010

1 reference

16 August 2017

Arthritis & Rheumatology

1 reference

16 August 2017

62

1 reference

16 August 2017

5

1 reference

16 August 2017

1494-1503

1 reference

FDA labeling system for drugs in pregnancy

16 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3633589

Teratogen update: reproductive risks of leflunomide (Arava); a pyrimidine synthesis inhibitor: counseling women taking leflunomide before or during pregnancy and men taking leflunomide who are contemplating fathering a child

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3633589

Predictive value of minor anomalies. I. Association with major malformations

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3633589

Pattern of malformations in the children of women treated with carbamazepine during pregnancy

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3633589

Course of pregnancy and fetal outcome following maternal exposure to carbamazepine and phenytoin: a prospective study.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3633589

Teratogenicity study of the dihydroorotate-dehydrogenase inhibitor and protein tyrosine kinase inhibitor Leflunomide in mice.

20 June 2018

1 reference

Paternal and maternal exposure to leflunomide: pregnancy and neonatal outcome

21 January 2018

1 reference

Postmarketing surveillance for human teratogenicity: a model approach.

21 January 2018

1 reference

Measurement of patient outcome in arthritis

21 January 2018

1 reference

Aplasia cutis congenita in surviving co-twins: four unrelated cases.

21 January 2018

1 reference

Unintended Pregnancy in the United States

21 January 2018

1 reference

The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3633589

CONGENITAL ANOMALIES IN THE NEWBORN INFANT, INCLUDING MINOR VARIATIONS. A STUDY OF 4,412 BABIES BY SURFACE EXAMINATION FOR ANOMALIES AND BUCCAL SMEAR FOR SEX CHROMATIN

26 November 2018

1 reference

12 December 2020

Pregnancy outcomes in women with rheumatoid arthritis in Washington State

1 reference

12 December 2020

Maternal exposure to leflunomide associated with blindness and cerebral palsy

1 reference

12 December 2020

Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases

1 reference

12 December 2020

Identifiers

DOI

10.1002/ART.27358

1 reference

16 August 2017

1 reference

16 August 2017

PubMed publication ID

20131283

1 reference